Skip to content
Invitrocue - Transforming bioanalytics
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)

ASX Announcements

Proposed issue of securities

November 10, 2017

Proposed issue of securities

Categories ASX Announcements

Quarterly Business Update and Investor Calls

October 31, 2017

Highlights for the quarter ending September 2017 

Categories ASX Announcements, Financial Reports

Appendix 4C – Quarterly Report

October 30, 2017

Appendix 4C – Quarterly Report

Categories ASX Announcements, Financial Reports

Notice of Annual General Meeting/Proxy Form

October 30, 2017

Notice of Annual General Meeting and Explanatory Statement

Categories ASX Announcements

Annual Report to Shareholders

September 29, 2017

Annual Report For The Period Ended 30 June 20167

Categories ASX Announcements

Appointments to the Management Team

September 28, 2017

Invitrocue announces appointments to the management team

Categories ASX Announcements

Preliminary Final Report

August 31, 2017

Preliminary Final Report: Download here.  

Categories ASX Announcements

IVQ receives award from Singapore government IP office

August 29, 2017

IVQ receives award from Singapore government IP office

Categories ASX Announcements, News, Press Releases

Investor Presentation

August 29, 2017

Investor Presentation

Categories ASX Announcements

Appendix 4C – Quarterly Report and Business Update

July 31, 2017

Appendix 4C – Quarterly Report and Business Update Investor Call  

Categories ASX Announcements, Financial Reports
Post navigation
Older posts
Newer posts
← Previous Page1 … Page10 Page11 Page12 … Page16 Next →

Recent Posts

  • Elephas Announces Commercial Partnership with Invitrocue to Expand Personalized Oncology in Southeast Asia
  • Xylonix and Invitrocue form strategic clinical alliance to validate new method for combating IL-6 pathologies
  • Invitrocue and Angsana partner with Averywell to advance early lung cancer detection across Asia
  • Invitrocue announces merger with Angsana Molecular & Diagnostics Laboratory and Pathnova Laboratories
  • Strategic partnership & Financial advisor appointment

GET IN TOUCH

51 Science Park Road, #01-11/13 The Aries, Singapore Science Park II Singapore 117586

GENERAL / PHARMACOLOGY ENQUIRIES:

+65 6460 0497
contact@invitrocue.com

ONCO-PDO ENQUIRIES:

+65 6819 0181
onco-pdo@invitrocue.com

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Logo Invitrocue
Icon-twitter-x Facebook-f Linkedin-in Youtube

© Copyright 2026 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings